'Excellent' Outcomes With Mitral ViV Procedures, Even in Lower-Risk Patients

Percutaneous mitral valve-in-valve is growing: should it be expanded to all patients regardless of surgical risk?

Related Keywords

Phoenix ,Arizona ,United States ,Tsuyoshi Kaneko ,Kashish Goel ,Edwards Lifesciences ,Amr Abbas ,Md Vanderbilt University Medical Center ,Gorav Ailawadi Md University Of Michigan ,Md William Beaumont University Hospital ,Md Washington University School Of Medicine ,Drug Administration ,Vanderbilt University Medical Center ,Washington University School ,Cases Growing ,Gorav Ailawadi ,Ann Arbor ,William Beaumont University Hospital ,Royal Oak ,